Aktuellt
SENASTE
Redeye gives its initial comments on the Q1 2024 report from Precise Biometrics, which came in above our expections. Sales was mostly in line with our estimates, landing c2% higher. However, the cost control from the company is especially impressive, leading to a noticeable improvement in profitability. We expect to raise our estimates and valuation on the back of the report.
LÄS MER
